Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK/RANKL pathway

Colorectal cancer (CRC) is the third most prevalent malignancy globally. Capecitabine is an important form of chemotherapy for colorectal cancer. The present study aims to investigate the underlying mechanism of action of the drug in CRC cells. In the present study, 50 pairs of CRC and adjacent norm...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Minghai, Jiang, Caiping, Yu, Changhui, Jia, Haijian, Wang, Yanli, Mao, Xinli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822391/
https://www.ncbi.nlm.nih.gov/pubmed/35154427
http://dx.doi.org/10.3892/ol.2022.13216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822391/
https://www.ncbi.nlm.nih.gov/pubmed/35154427
http://dx.doi.org/10.3892/ol.2022.13216

Ejemplares similares